BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3690537)

  • 1. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
    Wheelock J; Hancock K; Smith K
    Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed müllerian sarcoma: report of four cases.
    Patsner B; Greenberg S
    Gynecol Oncol; 1995 Sep; 58(3):386-8. PubMed ID: 7672707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
    Ohara N; Teramoto K; Murao S
    J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
    [No Abstract]   [Full Text] [Related]  

  • 5. [A carcinosarcoma of the ovary: a case report and a review].
    Ishihara H; Kanamori Y; Morishita K; Minagawa Y; Kigawa J; Matsui K
    Gan No Rinsho; 1990 Sep; 36(11):2105-9. PubMed ID: 2232179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of anthracyclines in first line combination chemotherapy of ovarian carcinoma.
    Conte PF
    Bull Cancer; 1993 Feb; 80(2):152-5. PubMed ID: 8173167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of neo-JP therapy in the treatment of ovarian carcinoma].
    Matsunami K; Takagi H; Hasegawa Y
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):153-5. PubMed ID: 7826073
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of a patient diagnosed with malignant mixed Müllerian tumor of the ovary who conceived after conservative surgery and adjuvant chemotherapy.
    Shibahara H; Wakimoto E; Mitsuo M; Ogasawara T; Takemura T; Koyama K
    Gynecol Oncol; 1997 May; 65(2):363-5. PubMed ID: 9159353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined chemotherapy including platinum derivatives in the combined treatment of patients with stage-III to -IV ovarian cancer].
    Perevodchikova NI; Gorbunova VA; Grigorova TM; Kozachenko VP; Marenich AF
    Vestn Akad Med Nauk SSSR; 1986; (5):8-11. PubMed ID: 3755271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy in advanced forms of carcinoma of the ovary].
    Calciati A; Clerico M; Donadio M; Giaccone G
    Minerva Ginecol; 1984 Apr; 36(4):195-8. PubMed ID: 6431334
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of advanced ovarian carcinoma with cyclophosphamide, adriamycin and cisplatin: evaluation of the therapeutic response and analysis of the collateral effects].
    Facchini V; Gadducci A; Ceccarelli P; Dell'Arciprete T; Del Bravo B; Bartolini T; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1986; 107(6):359-68. PubMed ID: 3566043
    [No Abstract]   [Full Text] [Related]  

  • 13. Chylothorax in a patient with ovarian tumour.
    Gupta PR; Taly A; Joshi N; Gupta S; Meena RC; Jain S
    Indian J Chest Dis Allied Sci; 2005; 47(1):43-6. PubMed ID: 15704715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy in clinical stage III cancer of the ovary. Use of 1 and 2 agents].
    Torres Lobatón A; García Baños J; Nieto Riande P; Flores López G; Martínez Macías R
    Ginecol Obstet Mex; 1986 Jan; 54():3-7. PubMed ID: 3699490
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An evaluation of two postoperative chemotherapy protocols in ovarian common epithelial cancer: a comparison of continuous and intermittent hospitalization].
    Sakamoto H; Suzuki H; Hayakawa S; Kiseki Y; Miyakawa Y; Ohkubo Y; Watanabe Y; Takami M; Kashiwazaki K; Tanaka H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1491-4. PubMed ID: 2584826
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of ovarian tumors using cis-platin].
    Laurová L; Kobilková J; Novotná J; Motlík K; Fricová M; Hornický J
    Cesk Gynekol; 1987 Feb; 52(1):41-4. PubMed ID: 3568161
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
    Barlow JJ; Lele SB
    Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Mucinous ovarian cancer.
    Omura GA
    Gynecol Oncol; 2005 Dec; 99(3):789; author reply 789-90. PubMed ID: 16125757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.